Janux Therapeutics, Inc. Business Finance Contracts & Agreements
12 Contracts & Agreements
- Investor Rights Agreements (2 contracts)
- Stock Agreements (3)
- Underwriting Agreements (4)
- Warrant Agreements (3)
- Form of Pre-Funded Warrant (Filed With SEC on December 5, 2024)
- Underwriting Agreement, dated December 4, 2024, by and among Janux Therapeutics, Inc. and BofA Securities, Inc., TD Securities (USA) LLC, Stifel, Nicolaus & Company, Incorporated,... (Filed With SEC on December 5, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on February 29, 2024)
- Underwriting Agreement, dated February 28, 2024, by and among Janux Therapeutics, Inc. and BofA Securities, Inc., Cowen and Company, LLC, Cantor Fitzgerald & Co. and William Blair... (Filed With SEC on February 29, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on July 18, 2023)
- Underwriting Agreement, between the Company and BofA Securities, Inc., dated as of July 17, 2023 (Filed With SEC on July 18, 2023)
- Description of Registrants Common Stock (Filed With SEC on March 18, 2022)
- Janux Therapeutics, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on June 7, 2021)
- Amended and Restated Investors Rights Agreement, by and between the registrant and certain of its stockholders, dated April 15, 2021, as amended (Filed With SEC on June 7, 2021)
- Form of Common Stock Certificate of the registrant (Filed With SEC on June 7, 2021)
- Form of Underwriting Agreement (Filed With SEC on June 7, 2021)
- Amended and Restated Investors Rights Agreement, by and between the registrant and certain of its stockholders, dated April 15, 2021 (Filed With SEC on May 19, 2021)
